Screening for celiac disease in Tunisian patients with Graves' disease using anti-endomysium and anti-tissue transglutaminase antibodies (Q39211218)

10 September 2017

Screening for celiac disease in Tunisian patients with Graves' disease using anti-endomysium and anti-tissue transglutaminase antibodies (English)

1 reference

10 September 2017

0 references

0 references

1 reference

Amani Mankaï

1

1 reference

10 September 2017

Molka Chadli-Chaieb

2

1 reference

10 September 2017

Fathia Saad

3

1 reference

10 September 2017

Leila Ghedira-Besbes

4

1 reference

10 September 2017

Mohamed Ouertani

5

1 reference

10 September 2017

Habib Sfar

6

1 reference

10 September 2017

Monia Limem

7

1 reference

10 September 2017

Majda Ben Abdessalem

8

1 reference

10 September 2017

Moncef Jeddi

9

1 reference

10 September 2017

Larbi Chaieb

10

1 reference

10 September 2017

Ibtissem Ghedira

11

1 reference

10 September 2017

1 August 2006

1 reference

Gastroenterologie Clinique et Biologique

10 September 2017

1 reference

10 September 2017

30

1 reference

10 September 2017

8-9

1 reference

10 September 2017

961-964

1 reference

Celiac disease-associated autoimmune endocrinopathies

10 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Endocrinological disorders and celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Non-thyroid autoantibodies in autoimmune thyroid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Clinical and subclinical autoimmune thyroid disease in adult celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Thyroid autoimmunity in childhood celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Autoimmune thyroid disorders and coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Prevalence of Coeliac Disease in Patients with Thyroid Autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Usefulness of screening program for celiac disease in autoimmune thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Coeliac disease in patients with autoimmune thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Celiac disease in children with autoimmune thyroid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Prevalence of silent celiac disease in patients with autoimmune thyroiditis from Northern Sardinia

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

[Anti-endomysium, anti-reticulin and anti-gliadin antibodies, value in the diagnosis of celiac disease in the child]

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Celiac disease in Tunisia: serological screening in healthy blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

IgA antiendomysium antibodies have a high positive predictive value for celiac disease in asymptomatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Endomysium antibodies in coeliac disease: an improved method

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

The relationship between anti-endomysium antibodies and villous atrophy in coeliac disease using both monkey and human substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Anti-transglutaminase IgA ELISA: clinical potential and drawbacks in celiac disease diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Is coeliac disease screening in risk groups justified? A fourteen-year follow-up with special focus on compliance and quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Development of celiac disease-associated antibodies in offspring of parents with type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

Severe osteomalacia due to undiagnosed coeliac disease: three case reports of Tunisian women

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973357-7

7 January 2021

10.1016/S0399-8320(06)73357-7

Identifiers

DOI

1 reference

10 September 2017

1 reference